Pay in 4 interest-free payments of $7.19 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Tirzepatide, a dual GLP-1 and GIP receptor agonist, can trigger telogen effluviuma type of temporary hair sheddingin some patients, usually appearing within weeks of starting treatment
Your provider will choose the administration route that matches your treatment plan and teach you how to properly give the injections if youll be doing them at home
It helps break down stored fat, increase energy expenditure, and enhance overall metabolic efficiency without affecting blood sugar levels
In SURPASS-2, tirzepatide showed greater HbA1c and weight reductions compared to semaglutide 1 mg
Combination Weight Loss (CagriSema) Extensive Research The Phase 3 REDEFINE 1 trial demonstrated that CagriSema (cagrilintide 2.4 mg plus semaglutide 2.4 mg) produced mean weight loss of 20.4% at 68 weeks in 3,417 adults with obesity or overweight without diabetes, compared to 14.9% with semaglutide alone, 11.5% with cagrilintide alone, and 3.0% with placebo
